BD
  • BD Worldwide
    • About BD
    • Contact BD
    • Careers
    • Products
    • Investors
    • News & Media
  • Privacy
  • Terms & Conditions
Site Map Advanced Search
EuropeEurope
Select another location

Diagnostic Systems

  • About Us
  • Products
  • Global Initiatives
  • Services
  • News & Events
  • Contact Us
  • Diagnostic Systems Home
  • Cancer
  • Growth and AST
  • HAI
  • Sepsis
  • STI
  • Tuberculosis
  • Industry

Cancer Detection Archive

E-mail
E-mail
Print
Print

3 January, 2012
BD is proud to support the ECCA for the 6th Annual Cervical Cancer Prevention Week in Europe (22-28 January 2012).

13 September, 2011
BD to Increase Access to Vital Cervical Cancer Screening in Resource-Limited Settings Through Commitment to Pink Ribbon Red Ribbon Initiative®

28 September, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer

12 September, 2009
Introducing the BD FocalPoint™ GS Imaging System

BD

1 Becton Drive

Franklin Lakes, NJ USA 07417

201.847.6800

 

Becton Dickinson GmbH

Tullastr. 8-12

D-69126 Heidelberg, Germany

Geschäftsführer: Matthias Borst

Amtsgericht Mannheim HRB 330 707

Tel.: +49 (0) 6221 305-0

Fax: +49 (0) 6221 305-216

Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2012 BD

  • Site Map
  • Privacy
  • Terms & Conditions
  • Permission Request
  • Trademarks
  • BD Worldwide